491 related articles for article (PubMed ID: 27943160)
1. Melanoma and Non-Melanoma Skin Cancer Associated with Angiotensin-Converting-Enzyme Inhibitors, Angiotensin-Receptor Blockers and Thiazides: A Matched Cohort Study.
Nardone B; Majewski S; Kim AS; Kiguradze T; Martinez-Escala EM; Friedland R; Amin A; Laumann AE; Edwards BJ; Rademaker AW; Martini MC; West DP
Drug Saf; 2017 Mar; 40(3):249-255. PubMed ID: 27943160
[TBL] [Abstract][Full Text] [Related]
2. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
3. Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.
Sargento L; Simões AV; Longo S; Lousada N; Dos Reis RP
Drugs Aging; 2016 Sep; 33(9):675-83. PubMed ID: 27568454
[TBL] [Abstract][Full Text] [Related]
4. Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States.
Eworuke E; Haug N; Bradley M; Cosgrove A; Zhang T; Dee EC; Adimadhyam S; Petrone A; Lee H; Woodworth T; Toh S
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33733052
[TBL] [Abstract][Full Text] [Related]
5. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
6. Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study.
Kang JH; Kao LT; Lin HC; Wang TJ; Yang TY
PLoS One; 2018; 13(6):e0199981. PubMed ID: 29953536
[TBL] [Abstract][Full Text] [Related]
7. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
8. Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.
Mamdani M; Gomes T; Greaves S; Manji S; Juurlink DN; Tadrous M; Kennedy SH; Antoniou T
JAMA Netw Open; 2019 Oct; 2(10):e1913304. PubMed ID: 31617924
[TBL] [Abstract][Full Text] [Related]
9. Risks of Melanoma and Nonmelanoma Skin Cancers Pre- and Post-Inflammatory Bowel Disease Diagnosis.
Narous M; Nugent Z; Singh H; Bernstein CN
Inflamm Bowel Dis; 2023 Jul; 29(7):1047-1056. PubMed ID: 35929649
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Ultraviolet Radiation Exposure and Skin Cancer Risk: the E3N-SunExp Study.
Savoye I; Olsen CM; Whiteman DC; Bijon A; Wald L; Dartois L; Clavel-Chapelon F; Boutron-Ruault MC; Kvaskoff M
J Epidemiol; 2018 Jan; 28(1):27-33. PubMed ID: 29176271
[TBL] [Abstract][Full Text] [Related]
11. Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients.
Moscarelli L; Zanazzi M; Mancini G; Rossi E; Caroti L; Rosso G; Bertoni E; Salvadori M
Clin Nephrol; 2010 Jun; 73(6):439-45. PubMed ID: 20497756
[TBL] [Abstract][Full Text] [Related]
12. Metal arc welding and the risk of skin cancer.
Heltoft KN; Slagor RM; Agner T; Bonde JP
Int Arch Occup Environ Health; 2017 Nov; 90(8):873-881. PubMed ID: 28766013
[TBL] [Abstract][Full Text] [Related]
13. Inverse association for diagnosis of Alzheimer's disease subsequent to both melanoma and non-melanoma skin cancers in a large, urban, single-centre, Midwestern US patient population.
Ibler E; Tran G; Orrell KA; Serrano L; Majewski S; Sable KA; Thiede R; Laumann AE; West DP; Nardone B
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1893-1896. PubMed ID: 29573497
[TBL] [Abstract][Full Text] [Related]
14. Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments.
Hirai T; Yamaga R; Fujita A; Itoh T
J Clin Pharm Ther; 2018 Dec; 43(6):829-835. PubMed ID: 29908131
[TBL] [Abstract][Full Text] [Related]
15. Associations among rotating night shift work, sleep and skin cancer in Nurses' Health Study II participants.
Heckman CJ; Kloss JD; Feskanich D; Culnan E; Schernhammer ES
Occup Environ Med; 2017 Mar; 74(3):169-175. PubMed ID: 27663986
[TBL] [Abstract][Full Text] [Related]
16. Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Koomen ER; Herings RM; Guchelaar HJ; Nijsten T
Cancer Epidemiol; 2009 Nov; 33(5):391-5. PubMed ID: 19896919
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
[TBL] [Abstract][Full Text] [Related]
18. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
Cardwell CR; Mc Menamin ÚC; Hicks BM; Hughes C; Cantwell MM; Murray LJ
BMC Med; 2014 Feb; 12():28. PubMed ID: 24521426
[TBL] [Abstract][Full Text] [Related]
19. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's Disease, Melanoma, and Keratinocyte Carcinoma: A Population-Based Study.
Lerman S; Amichai B; Weinstein G; Shalev V; Chodick G
Neuroepidemiology; 2018; 50(3-4):168-173. PubMed ID: 29566384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
